Through Network Pharmacology Combined with Artificial Intelligence Techniques, Potential Targets of Banxia Xiexin Decoction for the Treatment of Functional Dyspepsia were Identified and Validated
BXD may alleviate mast cell infiltration and mucosal barrier damage in FD by inhibiting the expression of p-STAT3, thereby exerting its therapeutic effects.
Authors
- Kinyu Shon
- Zhiguang Sun (ORCID: https://orcid.org/0000-0003-4990-4425)
- Xingqiu Ruan
- Ren Lang (ORCID: https://orcid.org/0000-0002-9712-8232)
- Ying Cheng (ORCID: https://orcid.org/0000-0002-8940-8445)
- Renjun Gu
- Cheng Chang (ORCID: https://orcid.org/0000-0001-5995-8326)
- Hanlin Dong (ORCID: https://orcid.org/0009-0008-7871-0789)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Nanjing University of Chinese Medicine (CN)
- Nanjing Traditional Chinese Medicine Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Yulin Orthopedics Hospital of Chinese and Western Medicine (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Current Computer - Aided Drug Design
- Published
- 2025-08-22
- DOI
- https://doi.org/10.2174/0115734099363762250812150637
- Citations
- 1
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.81